7x7 Health News » Urologix http://www.7x7health.com Health News Thu, 29 Jul 2010 17:35:24 +0000 en hourly 1 http://wordpress.org/?v=3.0 http://www.7x7health.com http://www.7x7health.com/wp-content/plugins/maxblogpress-favicon/icons/favicon-21.ico 7x7 Health News Urologix Reports Continued Revenue Growth in Second Quarter of Fiscal Year 2010 over Prior Periods http://www.7x7health.com/2010/01/22/urologix-reports-continued-revenue-growth-in-second-quarter-of-fiscal-year-2010-over-prior-periods/782 http://www.7x7health.com/2010/01/22/urologix-reports-continued-revenue-growth-in-second-quarter-of-fiscal-year-2010-over-prior-periods/782#comments Fri, 22 Jan 2010 21:16:40 +0000 Dana http://www.7x7health.com/?p=782 , Inc. (NASDAQ:ULGX), a company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy treatment catheters that provide a durable and effective procedure delivered in the comfort of an urologist’s office for patients suffering from benign prostatic hyperplasia (BPH), reported for the fiscal 2010 second quarter ended December 31, 2009.

2010 Second Quarter

Revenue for the second quarter ended December 31, 2009 was $4.1 million, or 20 percent more than the $3.4 million reported in the same quarter of fiscal year 2009. Revenue was 5 percent more than the $3.9 million reported in the first quarter of fiscal year 2010. The increase in revenue over the second quarter of fiscal year 2009 is due to increased sales in all distribution channels: , direct and third-party mobile services. The increase in revenue over the first quarter of fiscal 2010 is due to increased sales in direct and distribution channels.

Cash generated in the second quarter of fiscal year 2010 was $22,000. The Company’s cash balance was $6.0 million as of December 31, 2009, which management considers sufficient to fund working capital and capital resource needs beyond the next 12 months.

Net loss for the second quarter was $273,000, or a loss of $0.02 per diluted share. This compares to a net loss of $1.1 million or $0.07 per diluted share for the second quarter of fiscal 2009, and a loss of $677,000 or $0.05 per diluted share in the first quarter of fiscal year 2010.

In the second quarter of fiscal year 2010, revenue derived from the represented 48 percent of overall revenue, compared to 45 percent in the first quarter of fiscal 2010. The generated sequential revenue growth for the fifth consecutive quarter. Revenue from catheter sales to direct accounts contributed 35 percent of overall revenue in the second quarter of fiscal 2010, as compared to 33 percent in the first quarter of fiscal 2010. Third party mobile revenue represented approximately 15 percent of overall revenue in the second quarter of fiscal 2010, four percentage points lower than the 19 percent of revenue reported in the prior quarter of this fiscal year.

Gross profit for the second quarter of fiscal 2010 was $2.3 million, or 57 percent of revenue, compared to $1.8 million or 54 percent of revenue for the second quarter of fiscal 2009 and $2.1 million or 55 percent of revenue in the first quarter of fiscal 2010. The increase in gross margin compared to prior periods is primarily the result of cost benefits from increased production volumes in response to increased demand.

Operating expenses for the second quarter of fiscal 2010 decreased $265,000, or 9 percent, when compared to the second quarter of fiscal 2009 as we continue to manage our expenses. Operating expenses decreased $208,000, or 7 percent, when compared with the first quarter of fiscal 2010, primarily due to the timing of certain expenses related to our fiscal year-end reporting that are incurred in the first quarter.

, , ,

Related posts

]]> http://www.7x7health.com/2010/01/22/urologix-reports-continued-revenue-growth-in-second-quarter-of-fiscal-year-2010-over-prior-periods/782/feed 0 Urologix Reports Fiscal 2009 Results Including Sequential Growth in Fourth Quarter Fiscal Year 2009 Revenue http://www.7x7health.com/2009/08/26/urologix-reports-fiscal-2009-results-including-sequential-growth-in-fourth-quarter-fiscal-year-2009-revenue/484 http://www.7x7health.com/2009/08/26/urologix-reports-fiscal-2009-results-including-sequential-growth-in-fourth-quarter-fiscal-year-2009-revenue/484#comments Wed, 26 Aug 2009 18:05:44 +0000 Dana http://www.7x7health.com/?p=484 * Increased Revenue by 4% Compared to Third Quarter Fiscal 2009
* Reduced Net Loss by 27% Compared to Third Quarter Fiscal 2009
* Reduced Operating Expenses by 5% Compared to Third Quarter Fiscal 2009

, Inc. (NASDAQ:ULGX), a company focused on developing, manufacturing and marketing Cooled ThermoTherapy systems, a durable and effective catheter based in-office alternative to drugs or surgery for patients suffering from benign prostatic hyperplasia (BPH), reported for the fourth quarter ended June 30, 2009 and for fiscal year 2009.

2009 Fourth Quarter

Revenue for the fourth quarter was $3.4 million, or 4 percent more than the $3.3 million reported in the third quarter of this fiscal year; however, it was 6 percent less than the $3.7 million reported in the same period of fiscal 2008.

Net loss for the fourth quarter was $876,000, or a loss of $0.06 per diluted share. This compares to a net loss of $1.2 million or $0.08 per diluted share in the third quarter of fiscal 2009, and a loss of $2.2 million or $0.16 per diluted share for the fourth quarter of fiscal 2008.

Cash utilization for the quarter ended June 30, 2009 was $603,000, a 33 percent reduction from the cash utilization of the prior fiscal quarter and an 11 percent reduction from the cash utilization in the fourth quarter of fiscal 2008. The Company’s cash balance was $7.0 million as of June 30, 2009, which management considers sufficient to fund working capital and capital resource needs beyond fiscal year 2010.

, , , , ,

Related posts

]]> http://www.7x7health.com/2009/08/26/urologix-reports-fiscal-2009-results-including-sequential-growth-in-fourth-quarter-fiscal-year-2009-revenue/484/feed 0 Urologix to Host Its Fiscal Year 2009 and Fourth Quarter Conference Call http://www.7x7health.com/2009/08/20/urologix-to-host-its-fiscal-year-2009-and-fourth-quarter-conference-call/478 http://www.7x7health.com/2009/08/20/urologix-to-host-its-fiscal-year-2009-and-fourth-quarter-conference-call/478#comments Thu, 20 Aug 2009 17:37:16 +0000 Dana http://www.7x7health.com/?p=478 , Inc. (Nasdaq:ULGX) will host a to present fiscal year 2009 and fourth quarter on Tuesday, August 25, 2009 at 4:00 p.m. CT, following the Company’s post-market press release on the same day.

, , ,

Related posts

]]> http://www.7x7health.com/2009/08/20/urologix-to-host-its-fiscal-year-2009-and-fourth-quarter-conference-call/478/feed 0